Specific Drug Use Survey for EFIENT Tablets Prasugrel For Japanese patients with ACS in short-term clinical practice.
Phase of Trial: Phase IV
Latest Information Update: 19 May 2016
Price : $35 *
At a glance
- Drugs Prasugrel (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Acronyms PRASFIT-Practice I
- Sponsors Daiichi Sankyo Company
- 02 Apr 2015 Status changed from recruiting to completed as per University Hospital Medical Information Network - Japan.
- 31 Jul 2014 New trial record